AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Crotonylation of PRKACA enhances PKA activity and promotes colorectal cancer development via the PKA-FAK-AKT pathway

Jia-Yi Houa,b, Li-Juan Gaoa, Jing Shena, Lan Zhoua, Jian-Yun Shia, Teng Suna, Shu-Lan Haoc, De-Ping Wanga( ), Ji-Min Caoa( )
Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, Key Laboratory of Cellular Physiology of Shanxi Province, and the Department of Physiology, Shanxi Medical University, Taiyuan, Shanxi 030001, China
Department of Clinical Laboratory, Shanxi Provincial Academy of Traditional Chinese Medicine, Taiyuan, Shanxi 030012, China
Oncology Department, Shanxi Provincial Academy of Traditional Chinese Medicine, Taiyuan, Shanxi 030012, China

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Pages 332-335

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Hou J-Y, Gao L-J, Shen J, et al. Crotonylation of PRKACA enhances PKA activity and promotes colorectal cancer development via the PKA-FAK-AKT pathway. Genes & Diseases, 2023, 10(2): 332-335. https://doi.org/10.1016/j.gendis.2022.02.018

714

Views

8

Downloads

16

Crossref

16

Web of Science

17

Scopus

2

CSCD

Received: 05 December 2021
Published: 31 March 2022
© 2022 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).